This study is testing if adding ketamine to a therapy called Mindfulness-Oriented Recovery Enhancement (MORE) can help people with Opioid Use Disorder (OUD). You could be eligible if you have OUD and are currently receiving treatment with buprenorphine. The study will compare two groups: one receiving MORE therapy alone, and another receiving MORE therapy plus two sessions where ketamine (0.5 to 1.5 mg/kg) is given as a shot. The main goal is to see if the combination therapy reduces drug use over a three-month period. The current status of this study is unclear.

Study design

This is a randomized controlled trial planning to enroll 60 participants. It compares two different interventions for Opioid Use Disorder.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for drug use from the beginning of the study up to a 3-month follow-up.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.